Febrile seizure risk following monovalent COVID-19 mRNA vaccination in US children aged 2–5 years
Among children aged 2-5 years, the analysis showed a small elevated incidence rate ratio of febrile seizures in the 0-1 days following the mRNA-1273 vaccination.
Authors
- John D. Seeger (ORCID: https://orcid.org/0000-0002-8020-3144)
- Zhiruo Wan
- Yoganand Chillarige (ORCID: https://orcid.org/0000-0002-8020-6839)
- Kandace L. Amend (ORCID: https://orcid.org/0000-0002-8329-1522)
- Richard A. Forshee (ORCID: https://orcid.org/0000-0002-5805-2837)
- Kamran Kazemi
- Djeneba Audrey Djibo
- Lauren Parlett
- Mao Hu
- Cheryl N. McMahill-Walraven
- Jennifer Song
- Nandini Selvam
- Steven A. Anderson
- Alex Secora
- Elizabeth R. Smith
Institutions
- United States Food and Drug Administration (US)
- Wilmington University (US)
- New England College of Optometry (US)
- Acumen (United States) (US)
- IQVIA (United States) (US)
- CVS Health (United States) (US)
- Optum (United States) (US)
Publication Details
- Journal
- Vaccine
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1016/j.vaccine.2026.128225
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00